Active ingredientBiperidenCat. No. P-B085-001CAS 514-65-8Family · Pharmaceutical analytical standards
Biperiden
An anticholinergic synthesised in Germany by chemist W. Klavehn and approved in the United States in 1959: it is used against the symptoms of Parkinson's disease and the movement disorders caused by some antipsychotics. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Its molecule contains an unusual bicyclic skeleton, norbornene, a small 'cage' of seven carbon atoms. It is on the World Health Organization's List of Essential Medicines.
Go to the active ingredient →Active ingredientBiperidenCat. No. P-B085-001CAS 514-65-8
Active ingredientBiperiden HydrochlorideCat. No. P-B085-003CAS 1235-82-1
Pharmacopoeial impurityBiperiden EP Impurity ACat. No. P-B085-004CAS 2985510-53-8
Pharmacopoeial impurityBiperiden EP Impurity BCat. No. P-B085-006CAS 2984471-08-9
Pharmacopoeial impurityBiperiden EP Impurity CCat. No. P-B085-008CAS 2748308-78-1
Pharmacopoeial impurityBiperiden EP Impurity D HClCat. No. P-B085-010CAS 93778-70-2
Pharmacopoeial impurityBiperiden EP Impurity E HClCat. No. P-B085-011
Isotopically labelledBiperiden EP Impurity A-d5Cat. No. P-B085-012
Isotopically labelledBiperiden EP Impurity B-d5Cat. No. P-B085-013
Isotopically labelledBiperiden-d10Cat. No. P-B085-014
Isotopically labelledBiperiden-d5Cat. No. P-B085-015CAS 2938691-75-7
ImpurityBiperiden Epoxide N-OxideCat. No. P-B085-017
Pharmacopoeial impurityBiperiden EP Impurity DCat. No. P-B085-022CAS 475563-21-4
Pharmacopoeial impurityBiperiden EP Impurity ECat. No. P-B085-023CAS 2832847-11-5
ImpurityBiperiden N-OxideCat. No. P-B085-024CAS 2724689-97-6No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceBiperiden hydrochloride CRSEDQM code B1120000Family BiperidenImpurityBiperiden impurity A CRSEDQM code B1121000Family BiperidenNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.